India’s diagnostic network is expanding as healthcare companies add advanced imaging and pathology services.
India could become more than a market for CAR-T therapy. For Immuneel Therapeutics, it could become the base for global CAR-T growth. The Bengaluru-based biotech is building manufacturing capacity for India and future exports.
Drug research in India is undergoing a major shift as the government accelerates support for non-animal testing methods
Cancer patients facing rare and aggressive pancreatic tumors now gain renewed hope as the USFDA grants approval for Eli Lilly’s olomorasib
Ebola treatment efforts intensify as the WHO accelerates clinical trials in response to the outbreak in the Democratic Republic of the Congo
Surgical drug innovation takes center stage as Dr. Reddy’s Laboratories expands its US portfolio with the launch of Sugammadex injection
Childhood leukaemia remains a major health concern across the region. A new study shows India accounts for nearly 70% of South Asia's childhood leukaemia cases.
The Ebola outbreak in the Democratic Republic of Congo has become the second-largest on record globally
Ebola Vaccine gains momentum as Merck partners with a global health group to advance manufacturing to clinical supply by 2026
Sugammadex Injection strengthens Glenmark’s US portfolio as the company launches its generic version in the United States, targeting hospital segments
, CDSCO.jpg)